Investing.com -- Sanofi (EPA: SASY) shares fell more than 2% on Thursday after the pharmaceutical and healthcare company ...

Drugmaker Sanofi said on Thursday it believes the impact from U.S. tariffs to be manageable as it raised its sales growth ...

Sanofi UK General Manager Ahmed Moussa reflects on the current landscape of type 1 diabetes in the UK and explores what must ...

Net profit more than tripled to 3.94 billion euros, flattered by a gain from Sanofi's sale of a majority stake in its Opella consumer-healthcare arm. Business EPS came in at 1.59 euros, up 8.3% ...

In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a ...

France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong ...

PARIS, France I July 30, 2025 I The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an IgG1-based Antibody-Dependent ...

EWQ offers attractive value, robust dividend yield, and global diversification via French companies with significant ...

Pfizer Ltd rose 6.26% today to trade at Rs 5689.95. The BSE Healthcare index is up 0.15% to quote at 45404.45. The index is up 3.16 % over last one month. Among the other ...

Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition ...